Ardena launches integrated drug discovery support services
This year we’re back at CPhI Worldwide in Frankfurt to highlight our drug discovery support service program. We are excited...
Read moreNew website for NTRC Precision Medicine Services
NTRC Precision Medicine Services puts its cell-based profiling offers in the spotlight on the new website www.oncolines.com. The website focuses...
Read more
Citryll welcomed as 60th tenant
Pivot Park officially welcomed Citryll as the 60th tenant. “We are very pleased to have Citryll onboard our community, and...
Read more
Ongoing expansion of Acerta Pharma’s discovery and clinical operations in Oss
Acerta Pharma is one of the most successful pharmaceutical companies at Pivot Park. The discovery team has recently doubled in...
Read moreCitryll collaborates with leading NET researcher Dr. Markus Hoffmann
Oss, The Netherlands, Erlangen, Germany September 18, 2019 —http://www.citryll.com/ announced today that it has established a collaboration with Dr. Markus...
Read more
GLYCOSTEM signs two commercialisation agreements with Korean partner
OSS, Netherlands — On 9 September 2019 Glycostem and an undisclosed Korean partner confirmed the signing of two agreements. The...
Read morePivot Park welcomes LifeScience@Work Venture Challenge bootcamp
The LS@W Venture Challenge is a 10-week programme to develop an initial idea – a breakthrough research result – into...
Read more
Osteo-Pharma Release: Successful Preclinical Dental defect study Demonstrates Enhanced Bone Regeneration Properties of OsteoActivator coated collagen membranes
Osteo-Pharma, a Dutch Life Sciences company developing novel pharmaceuticals and medical devices to improve the local healing of bone fractures and defects, today has announced that it has successfully completed a large preclinical study in mini-pigs, which shows its OsteoActivator coated collagen membranes to effectively promote new bone formation.
Read more
“I liked academic work, but after my PhD I did not aspire to an academic career: I wanted to broaden my horizons.”
BioConnection, a spin-off of MSD/Organon, has undergone rapid development in recent years: from a consultant/broker without its own facilities to a production company that offers its Drug Product related services to medium-sized pharmaceutical players worldwide. The core business is the filling of medicines in various forms under GMP, mostly in vials and syringes. BioConnection works for customers at Pivot Park, but also globally for pharmaceutical companies in, amongst others, US, Europe, Australia, Brazil, Israel, , Korea and Taiwan.
Read more